These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 29819)

  • 21. Mucosal and plasma prostaglandin E2 in ulcerative colitis.
    Wiercinska-Drapalo A; Flisiak R; Prokopowicz D
    Hepatogastroenterology; 1999; 46(28):2338-42. PubMed ID: 10521993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The function of the cyclase system in ulcerative colitis].
    Zlatkina AR; Belousova EA; Vinnitskiĭ LI; Vorob'eva NT
    Sov Med; 1988; (3):10-3. PubMed ID: 2842873
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased nitric oxide synthesis in ulcerative colitis.
    Middleton SJ; Shorthouse M; Hunter JO
    Lancet; 1993 Feb; 341(8843):465-6. PubMed ID: 8094492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histamine content of rectal mucosa in ulcerative colitis.
    Binder V; Hvidberg E
    Gut; 1967 Feb; 8(1):24-8. PubMed ID: 6019985
    [No Abstract]   [Full Text] [Related]  

  • 25. Biopsy histamine in ulcerative colitis and Crohn's disease.
    Baenkler HW; Lux G; Günthner R; Kohlhäufl M; Matek W
    Hepatogastroenterology; 1987 Dec; 34(6):289-90. PubMed ID: 3428863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of rectal dialysis to determine intrarectal eicosanoids release in ulcerative colitis.
    Casellas F; Borruel N; Papo M; Antolín M; Armengol JR; Malagelada JR
    Rev Esp Enferm Dig; 1997 Apr; 89(4):280-8. PubMed ID: 9168661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis.
    Lauritsen K; Laursen LS; Bukhave K; Rask-Madsen J
    Gut; 1987 Sep; 28(9):1095-9. PubMed ID: 2824300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous expression of carcinoembryonic antigen in the normal colon and upregulation in active ulcerative colitis.
    Smithson JE; Warren BF; Young S; Pigott R; Jewell DP
    J Pathol; 1996 Oct; 180(2):146-51. PubMed ID: 8976872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of rectal mucosal catecholamines in ulcerative colitis.
    Penttilä O; Kyösola K; Klinge E; Ahonen A; Tallqvist G
    Ann Clin Res; 1975 Feb; 7(1):32-6. PubMed ID: 1155909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of cytokines in the pathogenesis of inflammatory intestinal diseases].
    Hommes DW; van Dullemen H; Radema SA; Tytgat GN; van Deventer SJ
    Ned Tijdschr Geneeskd; 1994 Dec; 138(49):2427-32. PubMed ID: 7997297
    [No Abstract]   [Full Text] [Related]  

  • 31. In-situ endothelial cell adhesion molecule expression in ulcerative colitis. E-selectin in-situ expression correlates with clinical, endoscopic and histological activity and outcome.
    Cellier C; Patey N; Fromont-Hankard G; Cervoni JP; Leborgne M; Chaussade S; Barbier JP; Brousse N
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1197-203. PubMed ID: 9471026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased transmural potential difference across the human rectum in ulcerative colits.
    Rask-Madsen J; Dalmark M
    Scand J Gastroenterol; 1973; 8(4):321-6. PubMed ID: 4729202
    [No Abstract]   [Full Text] [Related]  

  • 33. Control of thymidine incorporation in mucosal explants from patients with chronic ulcerative colitis.
    Alpers DH; Philpott G; Grimme NL; Margolis DM
    Gastroenterology; 1980 Mar; 78(3):470-8. PubMed ID: 6243267
    [No Abstract]   [Full Text] [Related]  

  • 34. Electrolyte transport capacity and electrical potentials of the normal and the inflamed human rectum in vivo.
    Rask-Madsen J; Jensen PB
    Scand J Gastroenterol; 1973; 8(2):169-75. PubMed ID: 4697079
    [No Abstract]   [Full Text] [Related]  

  • 35. [Transepithelial transport and electric potentials in the normal and inflamed human colon].
    Madsen JR
    Ugeskr Laeger; 1973 Jul; 135(29):1513-20. PubMed ID: 4598196
    [No Abstract]   [Full Text] [Related]  

  • 36. Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis.
    Raab Y; Sundberg C; Hällgren R; Knutson L; Gerdin B
    Am J Gastroenterol; 1995 Apr; 90(4):614-20. PubMed ID: 7717321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of salicylazosulfapyridine bioavailability following oral and rectal administration in patients with ulcerative colitis].
    Sliwiński Z
    Pol Tyg Lek; 1991 Nov 11-25; 46(45-47):879-81. PubMed ID: 1688291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukotrienes in Crohn's disease: effect of sulfasalazine and 5-aminosalicylic acid.
    Dreyling KW; Hoppe U; Peskar BA; Schaarschmidt K; Peskar BM
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():339-43. PubMed ID: 2889333
    [No Abstract]   [Full Text] [Related]  

  • 39. Verapamil inhibits in-vitro leucotriene B4 release by rectal mucosa in active ulcerative colitis.
    Gertner DJ; Rampton DS; Stevens TR; Lennard-Jones JE
    Aliment Pharmacol Ther; 1992 Apr; 6(2):163-8. PubMed ID: 1318088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis.
    Rampton DS; Sladen GE; Youlten LJ
    Gut; 1980 Jul; 21(7):591-6. PubMed ID: 7429322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.